209 related articles for article (PubMed ID: 7913124)
1. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway.
Martin LP; Waszczak BL
J Neurosci; 1994 Jul; 14(7):4494-506. PubMed ID: 7913124
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
Martin LP; Waszczak BL
Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
[TBL] [Abstract][Full Text] [Related]
3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
4. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
Waszczak BL
Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Cox RF; Waszczak BL
Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
[TBL] [Abstract][Full Text] [Related]
7. Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.
Yamamoto N; Soghomonian JJ
Neuroscience; 2008 Jun; 154(3):1088-99. PubMed ID: 18495353
[TBL] [Abstract][Full Text] [Related]
8. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
Florán B; Barajas C; Florán L; Erlij D; Aceves J
Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413
[TBL] [Abstract][Full Text] [Related]
10. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
11. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
13. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
[TBL] [Abstract][Full Text] [Related]
14. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
16. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
[TBL] [Abstract][Full Text] [Related]
17. The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
Meloni EG; Davis M
Psychopharmacology (Berl); 2004 Jul; 174(2):228-36. PubMed ID: 14735289
[TBL] [Abstract][Full Text] [Related]
18. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
[TBL] [Abstract][Full Text] [Related]
20. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
